» Articles » PMID: 38491377

Effects of Latroeggtoxin-VI on Dopamine and α-synuclein in PC12 Cells and the Implications for Parkinson's Disease

Overview
Journal Biol Res
Specialty Biology
Date 2024 Mar 16
PMID 38491377
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Parkinson's disease (PD) is characterized by death of dopaminergic neurons leading to dopamine deficiency, excessive α-synuclein facilitating Lewy body formation, etc. Latroeggtoxin-VI (LETX-VI), a proteinaceous neurotoxin discovered from the eggs of spider L. tredecimguttatus, was previously found to promote the synthesis and release of PC12 cells, showing a great potential as a drug candidate for PD. However, the relevant mechanisms have not been understood completely. The present study explored the mechanism underlying the effects of LETX-VI on dopamine and α-synuclein of PC12 cells and the implications for PD.

Results: After PC12 cells were treated with LETX-VI, the level of dopamine was significantly increased in a dose-dependent way within a certain range of concentrations. Further mechanism analysis showed that LETX-VI upregulated the expression of tyrosine hydroxylase (TH) and L-dopa decarboxylase to enhance the biosynthesis of dopamine, and downregulated that of monoamine oxidase B to reduce the degradation of dopamine. At the same time, LETX-VI promoted the transport and release of dopamine through modulating the abundance and/or posttranslational modification of vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT). While the level of dopamine was increased by LETX-VI treatment, α-synuclein content was reduced by the spider toxin. α-Synuclein overexpression significantly decreased the dopamine level and LETX-VI efficiently alleviated the inhibitory action of excessive α-synuclein on dopamine. In the MPTP-induced mouse model of PD, application of LETX-VI ameliorated parkinsonian behaviors of the mice, and reduced the magnitude of MPTP-induced α-synuclein upregulation and TH downregulation. In addition, LETX-VI displayed neuroprotective effects by inhibiting MPTP-induced decrease in the numbers of TH-positive and Nissl-stained neurons in mouse brain tissues.

Conclusions: All the results demonstrate that LETX-VI promotes the synthesis and release of dopamine in PC12 cells via multiple mechanisms including preventing abnormal α-synuclein accumulation, showing implications in the prevention and treatment of PD.

References
1.
Popova N, Gilinskii M, Amstislavskaya T . Effect of monoamine oxidase gene knockout on dopamine metabolism in mouse brain structures. Bull Exp Biol Med. 2004; 137(4):382-4. DOI: 10.1023/b:bebm.0000035137.97552.ab. View

2.
Yan S, Tang X, Yu D, Wang H, Meng W, Tang P . [Gene cloning, heterologous expression and activity identification of latroeggtoxin-Ⅵ]. Sheng Wu Gong Cheng Xue Bao. 2021; 37(2):635-645. DOI: 10.13345/j.cjb.200245. View

3.
Jin H, Romano G, Marshall C, Donaldson A, Suon S, Iacovitti L . Tyrosine hydroxylase gene regulation in human neuronal progenitor cells does not depend on Nurr1 as in the murine and rat systems. J Cell Physiol. 2005; 207(1):49-57. PMC: 1949423. DOI: 10.1002/jcp.20534. View

4.
Rebois R, Reynolds E, Toll L, Howard B . Storage of dopamine and acetylcholine in granules of PC12, a clonal pheochromocytoma cell line. Biochemistry. 1980; 19(6):1240-8. DOI: 10.1021/bi00547a031. View

5.
Qin H, Qin J, Hu J, Huang H, Ma L . Malva Sylvestris Attenuates Cognitive Deficits in a Repetitive Mild Traumatic Brain Injury Rat Model by Reducing Neuronal Degeneration and Astrocytosis in the Hippocampus. Med Sci Monit. 2017; 23:6099-6106. PMC: 5749139. DOI: 10.12659/msm.905429. View